Results summary | View all lists in L2L MDB | View all genes in L01A.profile.u50 |
Up-regulated at least 1.4-fold following treatment of MCF-7 human breast carcinoma cells with carcinogen benzo(a)pyrene (BaP), at any time point from 6-48 hours and at any concentration from 0.25-5 microM. enrichment: 13.95-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
221577_X_AT | GDF15 | C | S | ![]() |
![]() |
growth differentiation factor 15 | |||||||
202284_S_AT | CDKN1A | G | ![]() |
![]() |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | ||||||||
209160_AT | AKR1C3 | E | ![]() |
![]() |
aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) |